Last reviewed · How we verify
Hemophilia B
Approved treatments
- Qfitlia · Genzyme Corp
Qfitlia works by using small RNA molecules to block the production of antithrombin, a protein that can interfere with blood clotting.
Pipeline
- Nonacog Alfa (Genetical Recombination) · Pfizer Inc. — preclinical
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hemophilia B patent landscape — cliff calendar, originator estates, attackable patents
- Hemophilia B treatment landscape brief
- Hemophilia B treatment updates RSS
Frequently asked questions about Hemophilia B
What drugs treat Hemophilia B?
Tracked treatments include Qfitlia.
What is the treatment for Hemophilia B?
Standard treatment for Hemophilia B includes Qfitlia. See the treatment landscape page for first-line, second-line and salvage options.
What new drugs are in development for Hemophilia B?
1 pipeline drugs tracked. Top candidates: Nonacog Alfa (Genetical Recombination).
Related
- Treatment landscape: Hemophilia B patent cliff · Hemophilia B CI report
- Treatment: Qfitlia · Genzyme Corp
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing